Literature DB >> 8293641

Computed tomography of the lung in Wegener's granulomatosis.

G F Maskell1, C M Lockwood, C D Flower.   

Abstract

Computed tomography of the thorax was performed in 30 patients with Wegener's granulomatosis to define the anatomical basis of pulmonary involvement. A wide variety of parenchymal and bronchial abnormalities was demonstrated in addition to the cavitary nodules commonly described. The high incidence (40%) of bronchial abnormalities in these patients may suggest that bronchocentric injury is more important in the pathogenesis of lung involvement in this disease than has previously been considered. Serial scans in individual patients showed broad correlation between the extent of the pulmonary abnormalities and the clinical and immunological markers of disease activity.

Entities:  

Mesh:

Year:  1993        PMID: 8293641     DOI: 10.1016/s0009-9260(05)81104-3

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

Review 1.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  Air trapping in Wegener's granulomatosis: an additional finding on expiratory chest HRCT.

Authors:  E Magkanas; E Detorakis; I Nikolakopoulos; S Gourtsoyianni; M Linardakis; P Sidiropoulos; D Boumpas; N Gourtsoyiannis
Journal:  Radiol Med       Date:  2011-04-19       Impact factor: 3.469

4.  Chest CT findings in pediatric Wegener's granulomatosis.

Authors:  Daniel Levine; Jonathan Akikusa; David Manson; Earl Silverman; Rayfel Schneider
Journal:  Pediatr Radiol       Date:  2006-10-28

5.  Unilateral phrenic nerve paralysis in a patient with Wegener's granulomatosis.

Authors:  Omer Nuri Pamuk; Haluk Doğutan; Gülsüm Emel Pamuk; Necati Cakir
Journal:  Rheumatol Int       Date:  2003-02-05       Impact factor: 3.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.